Max Robotics — Global Service Robot Directory + US Certification

About

Sheng-Han Tsai is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for kidney and gastric cancers. His major contributions lie in systematically evaluating and comparing the outcomes of robotic-assisted and open surgical approaches, providing crucial evidence for clinical decision-making. His most impactful work, a 2018 systematic review and meta-analysis on robotic versus open partial nephrectomy, has garnered 62 citations, establishing a benchmark for perioperative outcomes in renal surgery. Tsai has also explored the frontiers of laparoscopic and robotic gastrectomy for gastric cancer, and investigated functional outcomes, such as split renal function preservation, after robot-assisted partial nephrectomy for tumors larger than 4 cm. Through these studies, Tsai has helped quantify the benefits of robotic surgery—including reduced blood loss and shorter hospital stays—while ensuring oncologic safety. His research is highly regarded by peers, as evidenced by the sustained citation of his work, and continues to shape modern urologic oncology by guiding surgeons toward less invasive, more precise interventions that improve patient recovery and quality of life.